CME Group Inc. (NASDAQ:CME) Holdings Decreased by Mendota Financial Group LLC

Mendota Financial Group LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 25.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 571 shares of the financial services provider’s stock after selling 199 shares during the period. Mendota Financial Group LLC’s holdings in CME Group were worth $133,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Franklin Resources Inc. raised its holdings in CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after buying an additional 1,003,119 shares during the period. Ameriprise Financial Inc. lifted its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares in the last quarter. International Assets Investment Management LLC boosted its stake in CME Group by 21,465.5% in the 3rd quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the period. Janus Henderson Group PLC grew its position in CME Group by 17.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock worth $554,707,000 after purchasing an additional 380,071 shares in the last quarter. Finally, Baillie Gifford & Co. purchased a new position in CME Group during the 3rd quarter worth approximately $79,692,000. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares of the company’s stock, valued at $2,403,279.44. The trade was a 8.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,274 shares of company stock worth $1,648,071. 0.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CME has been the topic of a number of research analyst reports. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Piper Sandler boosted their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Finally, Keefe, Bruyette & Woods decreased their target price on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research note on Monday. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $229.27.

CME Group Trading Up 0.1 %

Shares of CME stock opened at $229.45 on Tuesday. The company has a market cap of $82.69 billion, a PE ratio of 24.13, a price-to-earnings-growth ratio of 5.41 and a beta of 0.56. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The business’s 50 day moving average is $232.68 and its two-hundred day moving average is $219.11.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the business posted $2.25 EPS. Equities analysts predict that CME Group Inc. will post 10.22 EPS for the current year.

CME Group announced that its Board of Directors has initiated a share repurchase program on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.

CME Group Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, January 16th. Shareholders of record on Friday, December 27th will be issued a $5.80 dividend. This is a boost from CME Group’s previous dividend of $2.50. The ex-dividend date of this dividend is Friday, December 27th. CME Group’s dividend payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.